No profile data available.
Pulse Biosciences, Inc. (PLSE) is a healthcare company in the heart treatment equipment industry, based in Miami, United States, with about 116 full-time employees.
It reported revenue of $350,000 for fiscal year 2025, and net income of -$72.78 million. Its market capitalization was $3.84 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Pulse Biosciences reported $350,000 in revenue for fiscal year 2025.
$3.84 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Edwards Lifesciences Corporation (EW), Heartflow, Inc. (HTFL), LivaNova PLC (LIVN), iRhythm Technologies, Inc. (IRTC).